Found 396 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma PHASE2 This study will address the question of whether targeting CMV antigens with...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745) PHASE2 The primary purpose of the study is to evaluate the efficacy (overall respo...
Show More Location
Multiple Locations
Learn More & Join Trial
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma PHASE1 The goal of the Phase I part of this clinical research study is to find the...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma PHASE2 The primary protocol objective is to assess the impact of substituting puls...
Show More Status
Active Not Recruiting
Location
Medical College of Wisconsin
Learn More & Join Trial
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas) PHASE2 Purposes:
The purpose of this phase-II clinical trial is to determine whet...
Show More Location
China Medical University Hospital
Learn More & Join Trial
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET PHASE2 The purpose of the study is to evaluate the efficacy and tolerability of th...
Show More Location
Vienna General Hospital
Learn More & Join Trial
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. PHASE1 A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Show More Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Learn More & Join Trial
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas PHASE1 Objectives:
To determine maximum tolerated dose of farnesyl transferase in...
Show More Location
Duke University Health System
Learn More & Join Trial
Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma PHASE2 The overall objective of this study is to preliminarily evaluate the effica...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme PHASE2 This clinical trial evaluates adding high-dose ascorbate (vitamin C) to sta...
Show More Status
Active Not Recruiting
Location
Holden Comprehensive Cancer Center
Learn More & Join Trial